MedAvante Rolls Out Site Rater Software for CNS Trials

MedAvante, a provider of centralized assessments and quality control in clinical trials of treatments for central nervous system (CNS) disorders, announced the Virgil Investigative Study Platform for use by drug developers and their global cohort of trial sites. It allows clinicians at investigative sites to standardize rating scale administration and scoring across trials. Virgil software ranges from electronic rating scale forms, which provide clinical guidance to site raters as they administer an assessment, to operational workflows throughout the study process.

Link here for the full press release.